NHI National Health Investors Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Gaines Kristin Sallee	2. Issuer Name and Ticker or Trading Symbol NATIONAL HEALTH INVESTORS INC [ NHI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Credit Officer
(Last)          (First)          (Middle) 222 ROBERT ROSE DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 2/25/2021
(Street) MURFREESBORO, TN 37129 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								44609	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy) 2-25-2021	$69.20	2/25/2021		A		18333		2/25/2021	2/25/2026	Common Stock	18333	$0	18333	D
Stock Options (Right to Buy) 2-25-2021	$69.20	2/25/2021		A		18333		2/25/2022	2/25/2026	Common Stock	18333	$0	18333	D
Stock Options (Right to Buy) 2-25-2021	$69.20	2/25/2021		A		18334		2/25/2023	2/25/2026	Common Stock	18334	$0	18334	D
Stock Options (Right to Buy) 2-22-18 Exp 2-22-22	$74.78							2/22/2018	2/22/2022	Common Stock	16666		16666	D
Stock Options (Right to Buy) 2-22-19 exp 2-22-22	$74.78							2/22/2019	2/22/2022	Common Stock	16668		16668	D
Stock Options (Right to Buy) 2-20-18	$64.33							2/20/2019	2/20/2023	Common Stock	16666		16666	D
Stock Options (Right to Buy) 2-20-18	$64.33							2/20/2020	2/20/2023	Common Stock	16668		16668	D
Stock Options (Right to Buy) 2019	$79.96							2/21/2019	2/21/2024	Common Stock	18333		18333	D
Stock Options (Right to Buy) 2019	$79.96							2/21/2020	2/21/2024	Common Stock	18333		18333	D
Stock Options (Right to Buy) 2019	$79.96							2/21/2021	2/21/2024	Common Stock	18334		18334	D
Stock Options (Right to Buy) 2-21-2020	$90.79							2/21/2020	2/21/2025	Common Stock	18333		18333	D
Stock Options (Right to Buy) 2-21-2020	$90.79							2/21/2021	2/21/2025	Common Stock	18333		18333	D
Stock Options (Right to Buy) 2-21-2020	$90.79							2/21/2022	2/21/2025	Common Stock	18334		18334	D

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Gaines Kristin Sallee 222 ROBERT ROSE DRIVE MURFREESBORO, TN 37129			Chief Credit Officer

Signatures
/s/ Kristin S. Gaines		2/27/2021
**Signature of Reporting Person		Date